![]() |
Volumn 2, Issue 1, 2007, Pages 91-92
|
Unusual chemosensitivity of advanced bronchioalveolar carcinoma after gefitinib response and progression: A case report
|
Author keywords
Bronchioalveolar carcinoma; Chemotherapy; Gefitinib
|
Indexed keywords
CISPLATIN;
DOCETAXEL;
EPIDERMAL GROWTH FACTOR RECEPTOR KINASE;
ETOPOSIDE;
GEFITINIB;
NAVELBINE;
VINCA ALKALOID;
VINFLUNINE;
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR;
PROTEIN KINASE INHIBITOR;
QUINAZOLINE DERIVATIVE;
ADULT;
ADVANCED CANCER;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER RELAPSE;
CANCER RESISTANCE;
CASE REPORT;
CHEMOSENSITIVITY;
COMPUTER ASSISTED TOMOGRAPHY;
DOSE RESPONSE;
DRUG RESPONSE;
FEMALE;
FLUORESCENCE IN SITU HYBRIDIZATION;
FOLLOW UP;
GENE AMPLIFICATION;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
LUNG ALVEOLUS CELL CARCINOMA;
LUNG LOBECTOMY;
LYMPH NODE DISSECTION;
PALLIATIVE THERAPY;
PLEURECTOMY;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
DISEASE COURSE;
DRUG ANTAGONISM;
GENETICS;
LUNG TUMOR;
METASTASIS;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR;
ADULT;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COMBINED MODALITY THERAPY;
DISEASE PROGRESSION;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
PROTEIN KINASE INHIBITORS;
QUINAZOLINES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
|
EID: 34249665069
PISSN: 15560864
EISSN: 15561380
Source Type: Journal
DOI: 10.1016/s1556-0864(15)30026-5 Document Type: Article |
Times cited : (5)
|
References (3)
|